心臓病学と神経学における体外診断薬（IVD）の世界市場レポート 2025年

心臓病学と神経学における体外診断薬（IVD）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で240億7,000万米ドルに成長します。予測期間の成長は、循環器内科および神経内科における個別化医療へのシフト、循環器内科および神経内科における迅速かつオンサイトの検査ソリューションに対する需要の増加、遠隔医療および遠隔診察サービスの拡大、研究イニシアチブの高まりに起因すると考えられます。予測期間における主な動向としては、リキッドバイオプシー技術の出現、ナノテクノロジーの進歩、植え込み型心臓モニターやブレイン・コンピュータ・インターフェイスなどの遠隔モニタリング機器の採用、マルチプレックスバイオマーカーパネルの使用、MRI、CT、PETスキャンなどの医療用画像診断モダリティの革新、心血管・神経治療薬のコンパニオン診断薬の開発などが挙げられます。

個別化医療の拡大は、当面の間、心臓病学と神経学における体外診断薬（IVD）市場の発展を牽引することになるでしょう。個別化医療は、ヘルスケアへの介入や治療を個々の患者の特性に合うようにカスタマイズするもので、ゲノミクスの進歩、疾病メカニズムの理解の深化、オーダーメイド治療に対する患者の要望、規制当局の後ろ盾などの要因によって勢いを増しています。心臓病学と神経学では、体外診断用医薬品（IVD）検査は、個人の遺伝的構成と疾患の状態に関する重要な洞察を提供することにより、個別化医療を促進する上で極めて重要な役割を果たしています。このような洞察は、カスタマイズされた治療戦略の開発を導き、それによって有効性を高め、リスクを最小限に抑えます。例えば、個別化医療連合（Personalized Medicine Coalition）のデータによると、2022年には新たに承認された治療法の約34％が個別化医療であり、以前より大幅に増加しています。したがって、個別化医薬品の採用が拡大していることが、心臓病学と神経学における体外診断薬（IVD）市場の成長を促進しています。

心臓病学と神経学における体外診断薬（IVD）市場で事業を展開する主要企業は、疾患の早期発見やリスク評価を可能にするAI主導の統合エピジェネティック・システムを革新しています。これらのAI対応統合エピジェネティック・システムは、機械学習と高度なバイオマーカー分析手法を活用して、心血管疾患の診断とモニタリングの精度と感度を向上させ、それによって疾患の進展に影響を与える主要因をターゲットにしています。例えば、2023年2月、米国のバイオテクノロジー企業であるCardio Diagnostics Holdings Inc.は、冠動脈性心疾患（CHD）をタイムリーに特定するために設計されたAI搭載の血液検査であるPrecisionCHDを発表しました。同社の統合エピジェネティック・ジェネティックエンジンを採用したこの検査は、CHD感受性を評価し、最も一般的な心血管疾患の先制発見に努める。エピジェネティックおよび遺伝的指標を機械学習アルゴリズムと組み合わせることで、この新しい検査は男女ともに75％以上の感度を実現します。この検査は、患者のバイオマーカープロファイルと、CHDに大きく寄与する喫煙、糖尿病、高血圧、コレステロール値の上昇などの修正可能なリスク要素との関連性を確立します。PrecisionCHDは、クリニックまたは自宅で採取した血液サンプルが必要なため、運動負荷試験や血管造影検査などの従来の方法に対する非侵襲的な選択肢を提示します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓病学と神経学における体外診断薬（IVD） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心臓病学と神経学における体外診断薬（IVD）市場：成長率分析
• 世界の心臓病学と神経学における体外診断薬（IVD）市場の実績：規模と成長, 2019-2024
• 世界の心臓病学と神経学における体外診断薬（IVD）市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓病学と神経学における体外診断薬（IVD）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓病学と神経学における体外診断薬（IVD）市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬および消耗品
• ソフトウェアとサービス
• 世界の心臓病学と神経学における体外診断薬（IVD）市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定
• 分子診断
• 血液学
• その他のテクノロジー
• 世界の心臓病学と神経学における体外診断薬（IVD）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 臨床検査室
• その他のエンドユーザー
• 世界の心臓病学と神経学における体外診断薬（IVD）市場、機器のサブセグメンテーション：診断分析装置、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポイントオブケアデバイス
• 電気生理学デバイス
• 世界の心臓病学と神経学における体外診断薬（IVD）市場試薬および消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断試薬
• 検査キット
• アッセイ消耗品
• 世界の心臓病学と神経学における体外診断薬（IVD）市場ソフトウェアとサービスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断ソフトウェア
• データ管理ソフトウェア
• IVDコンサルティングおよびサポートサービス

第7章 地域別・国別分析

• 世界の心臓病学と神経学における体外診断薬（IVD）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓病学と神経学における体外診断薬（IVD）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓病学と神経学における体外診断薬（IVD）市場：競合情勢
• 心臓病学と神経学における体外診断薬（IVD）市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson And Company
• Quest Diagnostics Incorporated
• Hologic Inc.
• Illumina Inc.
• Beckman Coulter Inc.
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Instrumentation Laboratory
• bioMerieux SA
• Natera, Inc.
• Randox Laboratories Ltd.
• Fulgent Genetics Inc.
• DiaSorin S.p.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓病学と神経学における体外診断薬（IVD）市場2029：新たな機会を提供する国
• 心臓病学と神経学における体外診断薬（IVD）市場2029：新たな機会を提供するセグメント
• 心臓病学と神経学における体外診断薬（IVD）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

In vitro diagnostic (IVD) in cardiology and neurology involves conducting medical tests on samples such as blood, urine, or tissue outside the body to diagnose a range of cardiovascular and neurological ailments. These tests are pivotal for detecting conditions such as heart disease, stroke, Alzheimer's disease, and more, aiding in early diagnosis, ongoing monitoring, and treatment planning. They offer timely diagnostic insights crucial for guiding patient care and enhancing outcomes in both cardiology and neurology.

The main products of in vitro diagnostic (IVD) in cardiology and neurology encompass instruments, reagents and consumables, and software and services. Instruments denote the tools or apparatuses utilized for conducting diagnostic examinations and scrutinizing patient specimens within laboratory environments. These encompass various technologies such as immunoassays, molecular diagnostics, and hematology, catering to the needs of hospitals, clinical laboratories, and similar entities.

The in vitro diagnostic (IVD) in cardiology and neurology market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostic (IVD) in cardiology and neurology market statistics, including the in vitro diagnostic (IVD) in cardiology and neurology industry global market size, regional shares, competitors with in vitro diagnostic (IVD) in cardiology and neurology market share, detailed in vitro diagnostic (IVD) in cardiology and neurology market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostic (IVD) in cardiology and neurology industry. This in vitro diagnostic (IVD) in cardiology and neurology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostic (IVD) in cardiology and neurology market size has grown strongly in recent years. It will grow from $15.84 billion in 2024 to $17.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rise in the prevalence of age-related cardiovascular and neurological disorders, rise in the aging population, growing emphasis on preventive healthcare and early disease detection, the increasing burden of cardiovascular diseases (CVDs) and neurological disorders, such as stroke and Alzheimer's disease, rise in investments in healthcare infrastructure, and rise in supportive regulatory frameworks governing the approval and reimbursement of diagnostic tests.

The in vitro diagnostic (IVD) in cardiology and neurology market size is expected to see strong growth in the next few years. It will grow to $24.07 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the shift towards personalized medicine in cardiology and neurology, increasing demand for rapid and on-site testing solutions in cardiology and neurology, expansion of telemedicine and remote consultation services, and rise in research initiatives. Major trends in the forecast period include emergence of liquid biopsy technologies, advancements in nanotechnology, adoption of remote monitoring devices, such as implantable cardiac monitors and brain-computer interfaces, use of multiplex biomarker panels, innovations in medical imaging modalities, such as MRI, CT, and PET scans, and development of companion diagnostics for cardiovascular and neurological drugs.

The expansion of personalized medicine is poised to drive the advancement of the in vitro diagnostic (IVD) market in cardiology and neurology in the foreseeable future. Personalized medicine, which customizes healthcare interventions and treatments to suit the unique characteristics of individual patients, is gaining momentum due to progress in genomics, enhanced understanding of disease mechanisms, patient demand for tailored therapies, and regulatory backing, among other factors. In cardiology and neurology, IVD tests play a pivotal role in facilitating personalized medicine by furnishing essential insights into an individual's genetic composition and disease status. These insights guide the development of customized treatment strategies, thereby enhancing efficacy and minimizing risks. For instance, data from the Personalized Medicine Coalition indicates that in 2022, approximately 34% of all newly approved therapies were personalized medicines, marking a significant rise from previous years. Hence, the escalating adoption of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) market in cardiology and neurology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are innovating AI-driven integrated epigenetic systems to enable early detection of diseases and assess risks. These AI-enabled integrated epigenetic systems utilize machine learning and advanced biomarker analysis methods to improve the precision and sensitivity of diagnosing and monitoring cardiovascular conditions, thereby targeting key factors influencing disease advancement. For example, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology firm, introduced PrecisionCHD, an AI-powered blood test engineered for the timely identification of coronary heart disease (CHD). Employing the company's integrated epigenetic-genetic engine, this test evaluates CHD susceptibility and strives to preemptively detect the most prevalent cardiovascular ailment. Combining epigenetic and genetic indicators with machine learning algorithms, the new test delivers over 75% sensitivity for both genders. It establishes a connection between a patient's biomarker profile and modifiable risk elements, such as smoking, diabetes, hypertension, and elevated cholesterol levels, which significantly contribute to CHD. PrecisionCHD presents a non-invasive option to conventional methods such as exercise stress tests or angiograms, as it requires blood samples collected either at the clinic or home.

In March 2024, Beckman Coulter, a US-based company specializing in laboratory diagnostics, expanded its partnership with Fujirebio to focus on the development, manufacturing, and clinical adoption of neurodegenerative disease assays. This collaboration aims to combine their expertise in laboratory diagnostics and neurological markers to advance the development of innovative assays for diagnosing neurodegenerative diseases, ultimately improving patient outcomes through more accurate and timely diagnostics. Fujirebio, a Japan-based company, specializes in in vitro diagnostics (IVD) in cardiology and neurology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMerieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience

North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostic (IVD) in cardiology and neurology market consists of revenues earned by entities by providing services such as point-of-care testing, laboratory testing, molecular diagnostics, and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostic (ivd) in cardiology and neurology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostic (ivd) in cardiology and neurology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostic (ivd) in cardiology and neurology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
• 2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
• 3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
• Subsegments:
• 1) By Instruments: Diagnostic Analyzers; Point-Of-Care Devices; Electrophysiology Devices
• 2) By Reagents And Consumables: Diagnostic Reagents; Test Kits; Assay Consumables
• 3) By Software And Services: Diagnostic Software; Data Management Software; IVD Consulting And Support Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Characteristics

3. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Trends And Strategies

4. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Growth Analysis And Strategic Analysis Framework

• 5.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Growth Rate Analysis
• 5.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Total Addressable Market (TAM)

6. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Segmentation

• 6.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Consumables
• Software And Services
• 6.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassays
• Molecular Diagnostics
• Hematology
• Other Technologies
• 6.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinical Laboratories
• Other End-Users
• 6.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Instruments: Diagnostic Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point-Of-Care Devices
• Electrophysiology Devices
• 6.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Reagents
• Test Kits
• Assay Consumables
• 6.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Software
• Data Management Software
• IVD Consulting And Support Services

7. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Regional And Country Analysis

• 7.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 8.1. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 9.1. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 9.2. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 10.1. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 11.1. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 11.2. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 12.1. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 13.1. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 14.1. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 14.2. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 15.1. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 15.2. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 16.1. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 17.1. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 18.1. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 19.1. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 20.1. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 21.1. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 21.2. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 22.1. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 23.1. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 23.2. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 24.1. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 24.2. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 25.1. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 25.2. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 26.1. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 26.2. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 27.1. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 28.1. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 28.2. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 29.1. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 29.2. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape And Company Profiles

• 30.1. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape
• 30.2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Other Major And Innovative Companies

• 31.1. Becton Dickinson And Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. Hologic Inc.
• 31.4. Illumina Inc.
• 31.5. Beckman Coulter Inc.
• 31.6. Quidel Corporation
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QIAGEN N.V.
• 31.10. Instrumentation Laboratory
• 31.11. bioMerieux SA
• 31.12. Natera, Inc.
• 31.13. Randox Laboratories Ltd.
• 31.14. Fulgent Genetics Inc.
• 31.15. DiaSorin S.p.A.

32. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

34. Recent Developments In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

35. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market High Potential Countries, Segments and Strategies

• 35.1 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer